Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products. The company is headquartered in Cranford, New Jersey. Show more
11 COMMERCE DRIVE, CRANFORD, NJ, UNITED STATES, 07016, Cranford, NJ, 07016, USA
Market Cap
13.67M
52 Wk Range
$0.47 - $2.19
Previous Close
$0.57
Open
$0.56
Volume
1,808,178
Day Range
$0.56 - $0.68
Enterprise Value
11.57M
Cash
4.59M
Avg Qtr Burn
-1.30M
Insider Ownership
1.80%
Institutional Own.
4.16%
Qtr Updated
03/31/26
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
LYMPHIR (Denileukin Diftitox-cxdl, E7777) Details T-cell lymphoma | Approved Quarterly sales | |
Mino-Lok Details Catheter related blood stream infections | Phase 3 Update | |
Halo-Lido (CITI-102) Details Hemorrhoids | Phase 2b Update | |
Lymphir/Denileukin Diftitox-Cxdl (E7777) (IL-2R-Directed Cytotoxin) Details High-Risk Relapsed Or Refractory Diffuse Large B-Cell Lymphoma | Phase 1 Update | |
Pembrolizumab (KEYTRUDA®) + LYMPHIR™ Details Solid tumor/s | Phase 1 Update |
